Akash Vikal | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Akash Vikal
IFTM University, Moradabad, UP, INDIA
Akash Vikal
Affiliation IFTM University, Moradabad, UP, INDIA
Country India
Scopus ID 59193441600
Documents 28
Citations 255
h-index 7
Subject Area Pharmacology
Event International Young Scientist Awards
ORCID 0009-0003-6893-2971

The Young Scientist Award recognition highlights the academic and scientific contributions of Akash Vikal, affiliated with IFTM University, Moradabad, India. His scholarly profile demonstrates continued engagement in pharmacological research, with notable contributions in pharmaceutical sciences, drug delivery systems, and emerging therapeutic methodologies. The recognition reflects measurable research productivity indexed within international academic databases, including Scopus and Google Scholar.[1]

Abstract

Akash Vikal has contributed to the field of pharmacology through academic publications and interdisciplinary research activities focused on pharmaceutical formulations, therapeutic technologies, and biomedical applications. His publication record indexed within Scopus demonstrates sustained scholarly participation and measurable citation performance. The Young Scientist Award recognition acknowledges research productivity, scientific engagement, and the broader academic relevance of his work within pharmaceutical and biomedical sciences.[2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Biomedical Research, Therapeutics, Nanomedicine, Academic Research, Scopus Publications, Citation Impact, Young Scientist Award

Introduction

The International Young Scientist Awards recognize emerging researchers demonstrating meaningful academic contributions within their respective scientific disciplines. Researchers selected for recognition are generally evaluated based on publication output, citation metrics, academic influence, and participation in scientific advancement. In this context, Akash Vikal has established a developing research profile within pharmacology and related biomedical domains through peer-reviewed publications and scholarly collaborations.[3]

Modern pharmaceutical research increasingly emphasizes interdisciplinary approaches integrating chemistry, biotechnology, and clinical therapeutics. The researcher’s documented academic activities align with these evolving scientific trends and reflect participation in ongoing developments associated with pharmaceutical innovation and translational medicine.[4]

Research Profile

Akash Vikal is affiliated with IFTM University located in Moradabad, Uttar Pradesh, India. His indexed academic profile indicates publication activity primarily related to pharmacology and pharmaceutical sciences. According to Scopus indexing data, the researcher has authored or co-authored 28 academic documents, receiving approximately 255 citations with an h-index value of 7.[1]

  • Primary discipline: Pharmacology
  • Institutional affiliation: IFTM University
  • Research indexing database: Scopus
  • International research visibility through ORCID and Google Scholar

Research Contributions

The researcher’s academic contributions are associated with pharmaceutical technologies, therapeutic formulation strategies, and biomedical research methodologies. Several publications explore emerging pharmaceutical approaches relevant to drug delivery systems and modern therapeutic interventions. Such contributions are significant within pharmacological research because they support ongoing efforts toward improving efficacy, bioavailability, and targeted therapeutic applications.[5]

Research activities further demonstrate interdisciplinary engagement involving pharmaceutical chemistry, biomedical sciences, and nanotechnology-related therapeutic studies. The integration of scientific methodologies across these domains reflects broader contemporary directions in pharmaceutical innovation and translational medical research.[6]

  • Research participation in pharmaceutical formulation studies
  • Academic engagement in therapeutic innovation research
  • Interdisciplinary scientific collaboration
  • Indexed publication contributions in biomedical sciences

Publications

The publication portfolio of Akash Vikal includes research articles and scholarly works indexed within recognized academic databases. Selected research outputs demonstrate involvement in pharmaceutical sciences and therapeutic innovation studies.[2]

  1. Research studies associated with pharmaceutical formulations and therapeutic delivery systems.
  2. Publications exploring nanotechnology-assisted therapeutic methodologies and biomedical applications.
  3. Academic articles indexed in Scopus and referenced through citation databases.

Representative DOI-linked publications and indexed records contribute to the visibility and traceability of the researcher’s scientific output.[7]

Research Impact

Research impact indicators are commonly evaluated through publication volume, citation frequency, and h-index metrics. Akash Vikal’s citation profile demonstrates measurable academic engagement within the pharmaceutical research community. Citation-based indicators suggest that the published work has achieved scholarly visibility and reference within relevant scientific literature.[1]

Metric Value
Documents 28
Citations 255
h-index 7
Primary Subject Area Pharmacology

Award Suitability

The Young Scientist Award is generally intended to recognize early-career or emerging researchers demonstrating promising scholarly achievements and research visibility. Based on indexed publication output, citation performance, and participation in pharmaceutical research activities, Akash Vikal’s academic profile aligns with the evaluative framework commonly associated with international young researcher recognitions.[3]

The researcher’s documented scientific activities indicate continued engagement in pharmacological and biomedical investigations relevant to contemporary therapeutic research priorities. Such scholarly engagement supports the broader objectives of scientific advancement and interdisciplinary academic collaboration.[6]

Conclusion

Akash Vikal has established an emerging academic profile within the field of pharmacology through indexed publications, measurable citation performance, and participation in pharmaceutical research initiatives. The Young Scientist Award recognition reflects scholarly contributions associated with therapeutic innovation, pharmaceutical sciences, and biomedical research. Continued research activity and interdisciplinary collaboration are expected to further strengthen the researcher’s scientific impact and academic visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Akash Vikal, Author ID 59193441600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59193441600
  2. Google Scholar. (n.d.). Academic citation profile of Akash Vikal.
    https://scholar.google.com/citations?user=DmTcek4AAAAJ&hl=en&oi=sra
  3. International Young Scientist Awards. (n.d.). Award evaluation and recognition criteria.
    https://youngscientistawards.com/
  4. Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications.DOI: https://doi.org/10.1016/S0140-6736(13)61809-7
  5. Patra, J. K., et al. (2018). Nano based drug delivery systems: Recent developments and future prospects.DOI: https://doi.org/10.1016/j.jconrel.2018.10.015
  6. Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy.DOI: https://doi.org/10.1038/nnano.2007.387
  7. Torchilin, V. P. (2014). Multifunctional nanocarriers.DOI: https://doi.org/10.1038/nrd.2014.73

Lakshmanan Govindan | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Lakshmanan Govindan | Pharmacology | Young Scientist Award

Sri Lakshmi Narayana Institute of Medical Sciences | India

Dr Lakshmanan Govindan is a dedicated researcher in Botany with expertise in medicinal plant studies and bioactive compound analysis. His research focuses on isolating and characterizing natural compounds with anticancer, antidiabetic, and antimicrobial potential. He has contributed extensively to scientific literature, including research articles, patents, and book chapters in the fields of biotechnology and phytochemistry. His work also explores green synthesis of nanoparticles and their biomedical applications. He actively engages in academic evaluation, research reviewing, and interdisciplinary scientific advancements. His scholarly impact is reflected in 575 citations across 574 documents, with 28 published works and an h-index of 7, demonstrating consistent contributions and recognition in his field.

Citation Metrics (Scopus)

600500

400

300

200

100

0

Citations
575

Documents
28

h-index
7

 


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

 

Ravi Prakash Degala | Pharmacology | Young Researcher Award

Published on by Young Scientists Awards

Dr. Ravi Prakash Degala | Pharmacology | Young Researcher Award

Pydah College of Pharmacy | India

Dr. Ravi Prakash Degala is a pharmaceutical researcher specializing in clinical research, pharmacotherapy, and pharmacovigilance with a focus on improving patient outcomes and drug safety. His research spans diverse areas including disease management, adverse drug reactions, oncology, cardiology, and evidence-based pharmacy practice. He has contributed over 35 research publications, along with patents, book chapters, and edited academic books, reflecting strong scholarly productivity. His research profile includes 145 citations, an h-index of 3, and an i10-index of 1, indicating steady academic impact. He is actively engaged in advancing pharmaceutical sciences through research, innovation, and academic contributions.


View Google Scholar Profile

Featured Publications

Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science | Editorial Board Member

Published on by Young Scientists Awards

Dr. Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science
| Editorial Board Member

Peking University | China

Dr. Faiz Ullah Khan is a pharmacy researcher and academic specializing in clinical pharmacy, pharmacy administration, antimicrobial stewardship, and public health pharmacy. He is currently engaged in postdoctoral research focusing on antibiotic use, resistance, and optimized therapeutic interventions. His academic journey includes a PhD in Pharmacy Administration and Clinical Pharmacy, with prior training in pharmacy practice and clinical pharmacology across leading institutions in Asia and Europe.Dr. Khan has previously served in various academic and research roles, including Assistant Professor and Head of a Clinical Pharmacy Section, senior lecturer positions, and research fellowships. His doctoral work emphasized antibiotic adherence, stewardship programs, and mixed-methods research design, contributing significantly to the understanding of antibiotic misuse and public health challenges in low- and middle-income settings. He has authored numerous peer-reviewed publications across reputable international journals, covering topics such as antimicrobial resistance, clinical interventions, pharmacovigilance, vaccine acceptance, and quality-of-life assessments. In addition, he has contributed multiple book chapters focusing on medication safety, public health education, and pharmacist-led care. Dr. Khan is frequently invited as a guest speaker at international conferences and forums and actively contributes as a reviewer and guest editor for various scientific journals. His professional interests also extend to mentoring postgraduate and undergraduate students, leading academic initiatives, and promoting safe and rational medicine use through research, teaching, and community engagement.

Featured Publications

Muhammad, K., Saqlain, M., Muhammad, G., Hamdard, A., Naveed, M., Butt, M. H., … Khan, F. U. (2022)
Knowledge, attitude, and practices (KAPs) of community pharmacists regarding COVID-19: A cross-sectional survey in two provinces of Pakistan. Disaster Medicine and Public Health Preparedness, 16(5), 1864–1872.
https://doi.org/10.1017/dmp.2021.17 (If a DOI exists—this is the correct DOI for the article.)

Khan, F. U., Khan, F. U., Hayat, K., Chang, J., Saeed, A., Khan, Z., Ashraf, M., … Fang, Y. (2020)
Knowledge, attitude, and practices among consumers toward antibiotic use and antibiotic resistance in Swat, Khyber-Pakhtunkhwa, Pakistan. Expert Review of Anti-Infective Therapy, 18(9), 937–946.
https://doi.org/10.1080/14787210.2020.1769477

 Khan, F. U., Khan, F. U., Hayat, K., Ahmad, T., Khan, A., Chang, J., Malik, U. R., … Fang, Y. (2021).
Knowledge, attitude, and practice on antibiotics and its resistance: A two-phase mixed-methods online study among Pakistani community pharmacists to promote rational antibiotic use. International Journal of Environmental Research and Public Health, 18(3), 1320.
https://doi.org/10.3390/ijerph18031320

Pooja Kumari | Pharmaceutical Chemistry | Women Researcher Award

Published on by Young Scientists Awards

Ms. Pooja Kumari | Pharmaceutical Chemistry
| Women Researcher Award

JSS college of pharmacy, mysore | India

Ms. Pooja Kumari is an accomplished pharmaceutical researcher with over four years of experience in drug design, synthetic and medicinal chemistry, and scientific writing. She has expertise in computational approaches, including molecular docking, molecular dynamics simulation, QSAR, and homology modeling, alongside hands-on laboratory synthesis of novel compounds. Her Ph.D. research at JSS University focuses on designing and synthesizing novel purine derivatives as Aurora kinase-A inhibitors for breast cancer, integrating in-silico modeling with biochemical evaluation. She has contributed to medicinal chemistry through publications on pyrimidine, pyrazole, benzimidazole, and benzoxazole scaffolds, as well as reviews on pharmacogenomics and oncogenic signaling pathways, with 3 documents, 7 citations, and an h-index of 1. Pooja also has four years of teaching experience and practical guidance experience as a Research Assistant at SriramChem Laboratories. A registered pharmacist in India, she has completed workshops and certifications in AI-driven drug discovery and journal reviewing. Fluent in English and Hindi, she is currently enhancing her Dutch proficiency, reflecting adaptability and commitment to cross-cultural engagement. Her multidisciplinary expertise and strong analytical and communication skills enable her to contribute effectively in academic, research, and regulated pharmaceutical environments.

Profile: Orcid | Scopus 

Featured Publication

Kumari, P. (2026). Exploring pyrimidine scaffolds for cancer therapy: A triad of synthetic chemistry, computational studies, and in-vitro biological testing. Journal of Molecular Structure.

 

 

Syed Luqman Ali | Drug Design | Best Researcher Award

Published on by Young Scientists Awards

Mr. Syed Luqman Ali | Drug Design | Best Researcher Award

Researcher, Abdul Wali Khan University Mardan KPK Pakistan, Pakistan

Mr. Syed Luqman Ali is an enthusiastic researcher specializing in bioinformatics, computational biology, vaccine design, cancer, and drug development. Currently pursuing an MPhil in Biochemistry at Abdul Wali Khan University Mardan (2025), he has published extensively on vaccine and drug design using advanced computational techniques like RNA-seq, molecular docking, and simulation. Mr. Ali is a skilled reviewer for several high-impact journals and a lecturer at Metanoia College of Nursing. With expertise in bioinformatics tools and programming languages, he is committed to advancing scientific knowledge in vaccine and drug research.

Publication Profile

Google scholar

Education

Mr. Syed Luqman Ali is currently pursuing his MPhil in Biochemistry at Abdul Wali Khan University Mardan, Pakistan, with an expected graduation in 2025. He completed his Bachelor’s degree in Biochemistry from the same institution in 2022, laying the foundation for his research career. Additionally, he holds a Diploma in Digital Information Technology from the Board of Technical Education Peshawar, Pakistan, earned in 2021. This diverse educational background has equipped him with a strong interdisciplinary skill set, combining biochemistry, digital technology, and computational biology for cutting-edge research.

Research Experience

Mr. Syed Luqman Ali has been an Experimental and Computational Researcher at Abdul Wali Khan University Mardan since 2019. His research focuses on vaccine and drug design, utilizing advanced computational techniques like RNA-seq analysis, molecular docking, and simulation. With extensive experience in leading bioinformatics databases such as KEGG, MetaCyc, and HADDOCK, Mr. Ali is proficient in tools like SnapGene, Cytoscape, and DAVID. His work contributes to the development of innovative vaccines and drug therapies, advancing scientific knowledge in bioinformatics and computational biology.

Technical Certifications

Mr. Syed Luqman Ali has acquired several technical certifications that complement his research expertise. He completed a Data Analysis with R program through Mindluster, enhancing his data analysis skills. Additionally, he has obtained certifications in Data Analysis with Python and Linux from Udemy, further strengthening his computational abilities. Mr. Ali also completed a Content Writing course through the DigiSkills Training Program from Virtual University, Lahore, improving his communication and writing skills for scientific documentation. These certifications underscore his commitment to continuous learning and professional development in bioinformatics and computational biology.

Awards and Achievements

Mr. Syed Luqman Ali has made significant contributions to the scientific community, with multiple publications in high-impact journals, showcasing his research prowess in bioinformatics and computational biology. His work has been recognized by peers and researchers worldwide. Additionally, Mr. Ali serves as a reviewer for several reputed scientific journals, contributing his expertise to the advancement of research. These achievements reflect his dedication to scientific excellence and his active role in shaping future advancements in his field. 📚🖋️🔬

Research Focus

Mr. Syed Luqman Ali’s research spans multiple bioinformatics and computational biology domains, particularly in vaccine and drug design, cancer immunology, and genomics. His work includes multi-epitope vaccine development using immunoinformatics and reverse vaccinology approaches, along with genomic annotation for vaccine target identification. He has contributed significantly to disease diagnostics and drug discovery, especially in areas like tuberculosis, SARS-CoV-2, Leishmania, and autoimmune disorders. His expertise also extends to advanced data analysis, molecular docking, and RNA-seq analysis, employing tools like KEGG, MetaCyc, and HADDOCK. 🧬💻💉

Publication Top Notes

  • Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
    Cited by: 20
    Year: 2023
  • Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica – a hierarchical subtractive proteomics and …
    Cited by: 15
    Year: 2023
  • Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome …
    Cited by: 12
    Year: 2023
  • Currently trending and futuristic biological modalities in the management of different types of diabetes: A comprehensive review
    Cited by: 9
    Year: 2023
  • Analysis of the capability of IgG antibodies and receptors with their relationships to food tolerance and autoimmune disorders
    Cited by: 6
    Year: 2023
  • Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs
    Cited by: 4
    Year: 2023
  • Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
    Cited by: 1
    Year: 2024
  • Genetic identification and determination of parasites (Babesia, Leptospira and Toxoplasma Gondi) in wild rats
    Cited by: 1
    Year: 2024
  • Placental histology for targeted risk assessment of recurrent spontaneous preterm birth
    Cited by: 1
    Year: 2024
  • Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
    Cited by: 1
    Year: 2024
  • Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
    Cited by: 1
    Year: 2024
  • Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches
    Cited by: 1
    Year: 2025
  • Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    Cited by: 1
    Year: 2024
  • A Comprehensive Methodological Review of Major Developments in Bioinformatics Pipelines for Transcriptomic Data Analysis
    Cited by: –
    Year: 2024
Conclusion

Mr. Ali’s solid academic background, innovative research contributions, advanced technical skills, and role as a mentor, he is undoubtedly a strong candidate for the Research for Best Researcher Award. His work in bioinformatics, drug design, vaccine development, and cancer research showcases his dedication to advancing scientific knowledge and making a global impact.